Benefits from Prevention and Treatment
The criterion is partially established.
Mexico has national health implementation with general clinical outcomes for hepatitis C and studies in Tijuana documenting benefits from harm-reduction and drug-law-reform interventions. Proyecto Escudo provides the most direct evidence by combining local implementation, an observed reduction in incarceration risk, and modeled health benefits with a cost-effectiveness evaluation.
No contemporary national evaluation was identified that integrated prevention and treatment outcomes with avoided costs, productivity, crime, quality of life, intervention costs, and net benefit. National hepatitis C outcomes are also not disaggregated for people who inject drugs, while several available economic benefits derive from local or historical models.
Sources (8): the documents that support the traffic light
- Meta-synthesis of the work of UNODC in Mexico 2016-2023 (Document · 2024)
- Gobierno de México. (2023). *Reporte de la Estrategia Nacional para la Prevención de Adicciones (ENPA) 2023* (Regulation or programme · 2023)
- Bórquez, A., Beletsky, L., Nosyk, B., et al. (2018). The effect of public health-oriented drug law reform on HIV incidence in people who inject drugs in Tijuana, Mexico: an epidemic modelling study. The Lancet Public Health, 3(9), e429–e437 (Academic)
- Cepeda, J. A., Beletsky, L., Abramovitz, D., et al. (2024). Cost-effectiveness of a police education program on HIV and overdose among people who inject drugs in Tijuana, Mexico. The Lancet Regional Health – Americas, 30, 100679 (Academic)
- Cepeda, J. A., Beletsky, L., Abramovitz, D., et al. (2024). Cost-effectiveness of a police education program on HIV and overdose among people who inject drugs in Tijuana, Mexico. The Lancet Regional Health – Americas, 30, 100679 (Academic)
- Marquez, L. K., Fleiz, C., Burgos, J. L., Cepeda, J. A., McIntosh, C., Garfein, R. S., Kiene, S. M., Brodine, S., Strathdee, S. A., & Martin, N. K. (2021). Cost-effectiveness of hepatitis C virus elimination strategies among people who inject drugs in Tijuana, Mexico. Addiction, 116(10), 2734–2745 (Academic)
- Medina-Mora, M. E., García-Téllez, I., Cortina, D., Orozco, R., Robles, R., Vázquez-Pérez, L., Real, T., & Chisholm, D. (2010). Estudio de costo-efectividad de intervenciones para prevenir el abuso de alcohol en México. Salud Mental, 33(5), 373–378 (Academic)
- Secretaría de Salud. (2020). México aplica programa gratuito de eliminación de hepatitis C (Regulation or programme)
Links lead to the original document or to its archived copy.